Stocks To Watch Podcast Por Global One Media arte de portada

Stocks To Watch

Stocks To Watch

De: Global One Media
Escúchala gratis

Obtén 3 meses por US$0.99 al mes + $20 crédito Audible

Enjoy exclusive interviews with industry leaders from a wide range of listed small—and mid-cap companies and stay updated with the latest market and industry trends.

Hosted by Ashleigh Barry, Michael Switow, Michelle Martin, and Moneer Barazi, Global One Media invites top leaders and influencers from the crypto, small, and mid-cap space to join them for informative and in-depth discussions. With each episode, investors are provided with quality insights that are easy to digest and understand. Get the inside scoop on the latest global trends and insights from leaders in various industries.

Enjoying our episodes? Follow our podcast and hit the notification bell so that you don’t miss any new episodes.


Watch our Stock To Watch interviews on YouTube: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Copyright 2025 Global One Media
Economía Finanzas Personales Gestión y Liderazgo Liderazgo
Episodios
  • Episode 726: American Tungsten ($TUNG | $TUNGF) Strengthens Its Balance Sheet and Position in Tungsten Market
    Nov 14 2025

    American Tungsten (CSE: TUNG | OTCQB: TUNGF | FRA: RK90) continues to advance its position within the strategically important tungsten market.

    In this interview, CEO Ali Haji discusses key company updates, including the appointment of Duncan T. Blount to the Board of Directors, the completion of the second tranche of the LIFE Offering, the rehabilitation of the IMA Mine in Idaho, and tungsten’s rising importance across defense, nuclear energy, aerospace, and data centers.

    Learn more: https://americantungstencorp.com/

    Watch the full YouTube interview here: https://www.youtube.com/watch?v=4amH6svY_Qk
    And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

    Más Menos
    9 m
  • Episode 725: Advancing Humane Cancer Therapy: GT Biopharma's ($GTBP) Next-Gen Immunotherapy & Clinical Progress
    Nov 13 2025

    A breakthrough that could reshape cancer treatment.

    GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body’s own natural killer cells to identify and destroy cancer.

    In this interview, Executive Chairman & CEO Michael Breen discusses the company’s latest clinical progress and the potential of its lead drug candidate, GTB-3650.

    He also shares insights into the science behind TriKE®, the company’s pipeline for solid tumors and autoimmune diseases, and its mission to develop more humane cancer therapies that bring real hope to patients worldwide.

    Learn more about GT Biopharma: https://www.gtbiopharma.com/

    Watch the full YouTube interview here: https://youtu.be/jduKYNKHMIY
    And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

    Más Menos
    12 m
  • Episode 724: Building Energy Independence: Why Angkor Resources’ ($ANK) Block VIII Could Transform Cambodia
    Nov 12 2025

    Cambodia could be on the brink of an energy breakthrough.

    Angkor Resources (TSXV: ANK | OTCQB: ANKOF) is advancing a project that has the potential to be a true country maker. The onshore Block VIII venture could mark Cambodia’s first-ever domestic oil and gas discovery, opening doors for new industries, job creation, and long-term economic growth.

    In this interview, CEO Delayne Weeks shares how this milestone could reshape the nation’s energy landscape and why Block VIII remains Angkor Resources' top priority as the company moves toward drilling in late 2026.

    Learn more about Angkor Resources: https://angkorresources.com/

    Watch the full YouTube interview here: https://youtu.be/IqJtVpqjCgY
    And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

    Más Menos
    11 m
Todavía no hay opiniones